These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29530322)

  • 1. Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.
    Schlendorf KH; Zalawadiya S; Shah AS; Wigger M; Chung CY; Smith S; Danter M; Choi CW; Keebler ME; Brinkley DM; Sacks SB; Ooi H; Perri R; Awad JA; Lewis S; Hayes R; O'Dell H; Darragh C; Carver A; Edmonds C; Ruzevich-Scholl S; Lindenfeld J
    J Heart Lung Transplant; 2018 Jun; 37(6):763-769. PubMed ID: 29530322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C.
    Schlendorf KH; Zalawadiya S; Shah AS; Perri R; Wigger M; Brinkley DM; Danter MR; Menachem JN; Punnoose LR; Balsara K; Sacks SB; Ooi H; Awad JA; Sandhaus E; Schwartz C; O'Dell H; Carver AB; Edmonds CL; Ruzevich-Scholl S; Lindenfeld J
    JAMA Cardiol; 2020 Feb; 5(2):167-174. PubMed ID: 31851352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
    Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of heart transplantation from hepatitis C virus-positive donors.
    Aslam S; Yumul I; Mariski M; Pretorius V; Adler E
    J Heart Lung Transplant; 2019 Dec; 38(12):1259-1267. PubMed ID: 31521479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors.
    Smith DE; Chen S; Fargnoli A; Lewis T; Galloway AC; Kon ZN; Moazami N
    Semin Thorac Cardiovasc Surg; 2021; 33(2):407-415. PubMed ID: 32621962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
    Bethea ED; Gaj K; Gustafson JL; Axtell A; Lebeis T; Schoenike M; Turvey K; Coglianese E; Thomas S; Newton-Cheh C; Ibrahim N; Carlson W; Ho JE; Shah R; Nayor M; Gift T; Shao S; Dugal A; Markmann J; Elias N; Yeh H; Andersson K; Pratt D; Bhan I; Safa K; Fishman J; Kotton C; Myoung P; Villavicencio MA; D'Alessandro D; Chung RT; Lewis GD
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):771-780. PubMed ID: 31353243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accepting hepatitis C virus-infected donor hearts for transplantation: Multistep consent, unrealized opportunity, and the Stanford experience.
    Moayedi Y; Gulamhusein AF; Ross HJ; Teuteberg JJ; Khush KK
    Clin Transplant; 2018 Jul; 32(7):e13308. PubMed ID: 29869354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients.
    Zhu Y; Shudo Y; Lee R; Woo YJ
    Ann Transplant; 2020 Jun; 25():e922723. PubMed ID: 32527989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and heart transplantation: An update.
    Nunez M; Kelkar AA
    Clin Transplant; 2023 Oct; 37(10):e15111. PubMed ID: 37650430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
    Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
    Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C donor viremic cardiac transplantation: A practical approach.
    Morris KL; Adlam JP; Padanilam M; Patel A; Garcia-Cortes R; Chaudhry SP; Seasor E; Tompkins S; Hoefer C; Zanotti G; Walsh MN; Salerno C; Bochan M; Ravichandran A
    Clin Transplant; 2020 Jan; 34(1):e13764. PubMed ID: 31830339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
    Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
    Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation.
    Sawinski D; Patel N; Appolo B; Bloom R
    Transplantation; 2017 May; 101(5):968-973. PubMed ID: 27495759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches and strategies to manage the hepatitis C virus-positive heart donor.
    Lampert BC; Kissling K
    Curr Opin Organ Transplant; 2022 Jun; 27(3):229-234. PubMed ID: 35649114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Heart Transplant From a Hepatitis C Donor: New Antiviral Weapons Conquer the Trojan Horse.
    Gottlieb RL; Sam T; Wada SY; Trotter JF; Asrani SK; Lima B; Joseph SM; Gonzalez-Stawinski GV; Hall SA
    J Card Fail; 2017 Oct; 23(10):765-767. PubMed ID: 28801074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of heart transplantation using hepatitis c-viremic donors: A systematic review with meta-analysis.
    Villegas-Galaviz J; Anderson E; Guglin M
    J Heart Lung Transplant; 2022 Apr; 41(4):538-549. PubMed ID: 35153130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of a Hepatitis C-Positive Patient Who Received Kidney Transplant From a Hepatitis C-Positive Donor: A Case Report.
    Papayannis I; Patel P
    Prog Transplant; 2016 Sep; 26(3):238-40. PubMed ID: 27597771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
    Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
    J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of direct acting antiviral therapies in hepatitis C virus-negative liver transplant recipients of hepatitis C-viremic donors.
    Snyder HS; Wiegel JJ; Khalil K; Summers BB; Tan T; Jonchhe S; Kaiser TE
    Pharmacotherapy; 2022 Dec; 42(12):905-920. PubMed ID: 36373198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.